Metastatic squamous cell carcinoma of the skin with clinical response to lapatinib

ConclusionsCutaneous squamous cell carcinoma is the 2nd most common skin cancer in humans and future investigation of ERBB2 targeted therapies may provide an effective treatment strategy for patients with mutations in the ERBB2/3 pathway.

Source: Experimental Hematology and Oncology - August 28, 2018 Category: Cancer & Oncology Source Type: research